| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 288 | 288 | 288 | 788 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 288 | 288 | 288 | 788 | | | Operating Expenses | | Research Development | 3,945 | 3,681 | 3,497 | 3,695 | | Selling General and Administrative | 831 | 937 | 1,071 | 992 | | Non Recurring |
-
|
-
|
-
| (129) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,489) | (4,330) | (4,281) | (3,771) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (147) | 101 | 85 | 221 | | Earnings Before Interest And Taxes | (4,472) | (4,229) | (4,196) | (3,549) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (4,472) | (4,229) | (4,196) | (3,549) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,472) | (4,229) | (4,196) | (3,549) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,472) | (4,229) | (4,196) | (3,549) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,472) | ($4,229) | ($4,196) | ($3,549) |
|
0.51% Nasdaq 0.00%
Income Statement
